Health

The basis for competition in healthcare is shifting dramatically at a pace not seen over the past 30 years. In the face of escalating costs, quality challenges and uneven access to care, under pressure from continued economic challenges in Europe and healthcare reform in the US, companies in all healthcare sectors are reassessing how best to serve and succeed in the market.

Through all the uncertainty, what is clear is that companies will need to demonstrate measurable value, embrace the changing role of the consumer in healthcare, and harness fast-paced big advances in medical science, if they are to succeed in addressing these challenges. These are not issues that will be solved by one segment of the industry alone. A deep understanding of all stakeholders, engagement beyond single sectors, new uses of technology, and an ability to innovate will be required.

In many growth markets governments are facing the challenge of providing access to care to millions of individuals. Significant infrastructure investments and new institutions are required. On the private side, tailored market approaches are needed to ensure successful market entry and profitable growth.

Booz & Company works with leading healthcare organizations around the globe to navigate the different bases of competition and build the capabilities to deliver on that promise. Additional details on how we combine deep industry knowledge with extensive functional expertise to help our clients succeed can be found on our individual client pages: Payor, Health Systems & Other Providers, Life Sciences, Government Healthcare and Health NGOs & Advocacy Organizations.

Our Thought Leadership

The $5 PMPM Health Plan: Coming Soon to Your Neighborhood
New competitors in the health industry may soon be able to offer plans with cost as much as 80 percent lower than those of a typical plan today. If incumbent operators are to defend their market share from these upstart competitors, they must go far beyond their current, incremental approach to reducing costs.read more >

Putting an I in Healthcare
The days of the disengaged health consumer are numbered. Consumerization will transform healthcare systems, involving individuals as never before in the management of their own care.read more on strategy+business >

Bundled Care: The Voice of the Consumer
The goal of extending healthcare to all Americans at affordable prices and with no sacrifice in quality, will require huge changes.read more >

A Strategist’s Guide to Personalized Medicine
Breakthroughs in pharmaceutical innovation are poised to change the prevailing business model of the industry — with dramatic effects on healthcare costs and practice. read more on strategy+business >

Health System Fitness
In an environment of reimbursement reductions and declining revenue yields, stepwise cost reductions of 10 percent or more will be a top priority for hospitals and health systems. To achieve this level of savings and continue to fulfill their missions, hospitals and health systems will need a proven approach capable of producing transformational cost reduction.read more >

Winning in the Medicaid and “Duals” Markets: Navigating Uncertainty and Planning for Successful Growth
Despite the Supreme Court’s recent decision to allow individual states to opt out of the Medicaid expansion provision of the Affordable Care Act, Medicaid rolls will soon expand by millions of people. Indeed, this decision is just one element of the changing Medicaid landscape.read more >

The Emergence of Private Health Insurance Exchanges
Health insurance in the U.S. is at the cusp of a major transition from an employer-driven payor model to a model directly involving many more employees and consumers. Private health insurance exchanges with a defined contribution approach represent a significant step toward catalyzing this change.read more >

Five Steps toward a Revitalized Pharmaceutical Supply Chain
Global drug companies are facing disruption. One powerful strategic response is to rethink their manufacturing and operations footprints. read more on strategy+business >

Healthcare after the Ruling: Let the Work Continue
The Supreme Court’s decision to uphold the Affordable Care Act (ACA) means that the transformational changes already underway in the healthcare system will accelerate in three key areas: expanded access for individuals via health insurance exchanges and expanded Medicaid eligibility. read more >

Big Pharma’s Uncertain Future
The business model that drove the major drugmakers’ success isn’t working anymore. The survivors will be those that make smart strategic bets supported by winning capabilities. read more on strategy+business >

The Future of Health Insurance
Our research suggests that traditional employer-based insurance will remain a significant market that will erode more slowly and less steeply than commonly thought. Ultimately, employer-sponsored plans will serve as the foundation for insurers’ future growth no matter how healthcare reform shakes out.read more >

Transforming the Value Proposition in Pharmaceutical Marketing
For decades the pharmaceutical industry’s direct-to-physician marketing model worked extremely well. Now, at a time when industry fundamentals are already challenging, companies must transform their marketing models to comprehensively focus on value creation.read more >

Health Insurance Gets Personal
As reform legislation makes the U.S. healthcare industry more consumer-centric, companies will need to change their business models and add new capabilities. read more on strategy+business >

Payor/Provider Industry Perspective for 2013
Healthcare reform is now inevitable, and that will lead payors, providers, and hospital systems to think differently this year—about consumers, costs, technology, and acquisitions. read more >

Life Sciences (Pharmaceuticals) Industry Perspective for 2013
After the roller-coaster year of 2012, it’s easy to overlook the exciting opportunities in life sciences: technological advances, new business models, and global markets. read more >

read more health thought leadership >

How We Help Our Clients

payor provider life sciences government ngos

We support a broad array of payors and other stakeholders across medical and ancillary insurance industries with their strategic agenda. As pragmatic strategists, we help define total solutions for our clients that are grounded in developing a set of coherent, differentiating capabilities, to maintain long-term sustainability and profitable growth in the face of healthcare affordability challenges and regulatory headwinds. We also help our clients design and build the related operating models to execute against their chosen strategic path. read more >

We work with hospitals, health systems, physician groups, and other healthcare service providers, including home health, long-term care, and diagnostic services companies. We help our clients address today’s greatest challenges facing healthcare delivery globally - keeping healthcare costs down, improving patient experience, and delivering and demonstrating better outcomes. read more >

Booz & Company works with blue-chip pharmaceutical, medical device, diagnostic, and other life science companies to help them succeed in the changing market environment. We bring a truly differentiated ability to not only develop strategy but also help deliver value, build and embed new capabilities, and effect change. We combine deep functional expertise in strategy, operations, information technology, and organization with a unique strategic perspective based on our leading position working with the managed care customers of life sciences companies and our collaboration with the leading consultants to U.S. government health agencies. read more >

Booz & Company has a history of serving government organizations around the world, including Europe, the Middle East, Asia and the United States. We provide a full range of strategy, technology, analytic, operational and transformational expertise to these clients. Our experience includes helping governments design and stand up new healthcare infrastructure, design electronic health record systems and stand up new regulatory agencies. Booz & Company also supports clients at the intersection of government and industry, working with a number of public/private partnerships and collaborations. read more >

Booz & Company partners with non-governmental organizations worldwide to help advance a variety of health-related missions. We work with NGOs to define their strategic focus as well as help them build the capabilities needed to promote their mission, acting both on their own as well as in concert with other organizations. Booz & Company brings particularly deep expertise in fostering collaborative partnerships across the NGO, private, and public sectors. read more >

Consumerization
Consumers are being called upon to take a greater hand in managing and paying for their own health. Significant change will be required to thrive in a consumer-centric environment. The winning players will be those health care companies that can successfully apply a deep, nuanced understanding of consumers to the development of new business models, capabilities, and offerings. read more >

Personalized Medicine (PMx)
Personalized medicine (PMx) enables the right therapy to be delivered to the right patient at the right time and is critical to the continued success of the healthcare industry. Our personalized medicine practice helps clients move from concept to action, whether it is enterprise-wide transformation, functional capability enhancements, or product-specific companion diagnostic opportunities. read more >

Client Examples

Payor Strategy
A large health plan articulated a vision for the future – but hit roadblocks in translating this vision into a prioritized strategy and in operationalizing the strategy. Find out how Booz & Company helped. read more >

Transformative Cost Reduction for a Regional Health System
Faced with a future of reimbursement reductions and declining revenue yields, a large regional health system set an ambitious goal of achieving a 20% reduction on its $500 million cost base for centralized and facility-based support functions. Booz & Company helped the leadership team identify up to $120 million in annual savings and $13 million in margin improvement. read more >

Value Capture Through Digital Channels and Partnership
A pharmaceutical company was struggling to grow revenues for several key primary care products by tapping into ‘lost patients’ that fell out of the diagnosis/treatment/fulfilment pathway. Booz & Company was engaged to analyze the market opportunity, identify critical “pain points” and characterize value capture opportunities which could be addressed by digital solutions. read more >